MOD vs. BBIO
MOD (Modine Manufacturing Company) and BBIO (BridgeBio Pharma, Inc.) are both stocks. MOD operates in Auto Parts (Consumer Cyclical), while BBIO operates in Biotechnology (Healthcare). Over the past 5 years, MOD returned 73.98%/yr vs 0.88%/yr for BBIO. At a 0.25 correlation, their price movements are largely independent.
Performance
MOD vs. BBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MOD achieves a 105.60% return, which is significantly higher than BBIO's -12.67% return.
MOD
- 1D
- 1.10%
- 1M
- -1.68%
- YTD
- 105.60%
- 6M
- 96.24%
- 1Y
- 182.79%
- 3Y*
- 103.03%
- 5Y*
- 73.98%
- 10Y*
- 39.93%
BBIO
- 1D
- -1.11%
- 1M
- -2.64%
- YTD
- -12.67%
- 6M
- -11.11%
- 1Y
- 68.47%
- 3Y*
- 58.58%
- 5Y*
- 0.88%
- 10Y*
- —
MOD vs. BBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
MOD Modine Manufacturing Company | 105.60% | 15.16% | 94.19% | 200.60% | 96.83% | -19.67% | 63.12% | -44.36% |
BBIO BridgeBio Pharma, Inc. | -12.67% | 178.75% | -32.03% | 429.79% | -54.32% | -76.54% | 102.88% | 14.51% |
Correlation
The correlation between MOD and BBIO is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.28 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Jun 27, 2019 | 0.25 |
Fundamentals
MOD:
$14.82B
BBIO:
$13.01B
MOD:
$4.66
BBIO:
-$3.76
MOD:
4.62
BBIO:
22.81
MOD:
$3.18B
BBIO:
$566.04M
MOD:
$731.10M
BBIO:
$538.20M
MOD:
$276.90M
BBIO:
-$602.24M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MOD vs. BBIO — Risk / Return Rank
MOD
BBIO
MOD vs. BBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Modine Manufacturing Company (MOD) and BridgeBio Pharma, Inc. (BBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MOD | BBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.28 | ||
| Sortino ratioReturn per unit of downside risk | +0.91 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.29 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 6.68 | 3.40 | +3.28 |
| Martin ratioReturn relative to average drawdown | 19.05 | 8.27 | +10.79 |
Loading charts...
Drawdowns
MOD vs. BBIO - Drawdown Comparison
The maximum MOD drawdown since its inception was -97.53%, which is greater than BBIO's maximum drawdown of -92.80%. Use the drawdown chart below to compare losses from any high point for MOD and BBIO.
Loading charts...
Drawdown Indicators
| MOD | BBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.53% | -92.80% | -4.73% |
Max Drawdown (1Y)Largest decline over 1 year | -27.55% | -20.25% | -7.30% |
Max Drawdown (3Y)Largest decline over 3 years | -51.61% | -49.08% | -2.53% |
Max Drawdown (5Y)Largest decline over 5 years | -56.14% | -91.89% | +35.75% |
Max Drawdown (10Y)Largest decline over 10 years | -88.13% | — | — |
Current DrawdownCurrent decline from peak | -10.55% | -16.41% | +5.86% |
Average DrawdownAverage peak-to-trough decline | -37.66% | -45.77% | +8.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.64% | 8.31% | +1.33% |
Volatility
MOD vs. BBIO - Volatility Comparison
Modine Manufacturing Company (MOD) has a higher volatility of 25.85% compared to BridgeBio Pharma, Inc. (BBIO) at 10.47%. This indicates that MOD's price experiences larger fluctuations and is considered to be riskier than BBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MOD | BBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.85% | 10.47% | +15.38% |
Volatility (6M)Calculated over the trailing 6-month period | 52.74% | 34.18% | +18.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 66.82% | 46.52% | +20.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 60.36% | 85.91% | -25.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 58.84% | 83.77% | -24.93% |
Dividends
MOD vs. BBIO - Dividend Comparison
Neither MOD nor BBIO has paid dividends to shareholders.
Financials
MOD vs. BBIO - Financials Comparison
This section allows you to compare key financial metrics between Modine Manufacturing Company and BridgeBio Pharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MOD vs. BBIO - Profitability Comparison
MOD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Modine Manufacturing Company reported a gross profit of 214.70M and revenue of 954.40M. Therefore, the gross margin over that period was 22.5%.
BBIO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported a gross profit of 178.39M and revenue of 180.60M. Therefore, the gross margin over that period was 98.8%.
MOD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Modine Manufacturing Company reported an operating income of 96.40M and revenue of 954.40M, resulting in an operating margin of 10.1%.
BBIO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported an operating income of -105.96M and revenue of 180.60M, resulting in an operating margin of -58.7%.
MOD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Modine Manufacturing Company reported a net income of 201.50M and revenue of 954.40M, resulting in a net margin of 21.1%.
BBIO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported a net income of -164.04M and revenue of 180.60M, resulting in a net margin of -90.8%.
Frequently Asked Questions
MOD and BBIO have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MOD has higher volatility (25.85%) compared to BBIO (10.47%). In terms of maximum drawdown, MOD dropped -97.53% vs BBIO's -92.80%.
MOD currently has the higher Sharpe Ratio (2.75 vs 1.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MOD and BBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer